Key facts
- Status: Privately Held (backing).
- ·Watchlist + deal alerts for Dongfang Shenzhou Biotechnology
- ·The full record, as it builds
Funding rounds
No funding rounds for Dongfang Shenzhou Biotechnology are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Dongfang Shenzhou Biotechnology
Manufacturer of plant-based empty capsules designed to support safe and compliant pharmaceutical and nutraceutical formulations. The company offers hydroxypropyl methylcellulose capsule production, integrated research and manufacturing capabilities, and stringent international quality certifications, enabling pharmaceutical and health product manufacturers to achieve consistent dosage delivery with plant-derived materials and reliable regulatory acceptance.
- Sector
- Healthcare
- HQ
- Yantai, China
- Founded
- 2004
- Website
- dfcapsules.com/
- Ownership
- Privately Held (backing)
Dongfang Shenzhou Biotechnology doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Dongfang Shenzhou Biotechnology shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Dongfang Shenzhou Biotechnology in its N-PORT filings yet. We sweep new filings monthly.